Stockscreener 앱 받기
31.38
0.48%
0.15
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Published on: 2026-01-18 05:20:30 - baoquankhu1.vn
Portfolio Recap: Does SKLZ stock benefit from AI growthJuly 2025 Volume & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Market Review: Is Hims Hers Health Inc a top pick in the sectorMarket Risk Report & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Hims GLP-1 Weight Loss Guide 2026: Injectable and Oral Treatment Options for Men (Semaglutide and Tirzepatide) - Newswire.com
Hims & Hers And HIMZ: Short‑Term Pain From Novo, Long‑Term Opportunity Still Bright (HIMS) - Seeking Alpha
Looking For A Short Squeeze? 10 Stocks Ready To Rocket - Benzinga
Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now? - Yahoo Finance
Hims & Hers Shares Face Heightened Volatility on Key Expiry Date - AD HOC NEWS
Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s - Sherwood News
Best Healthcare Stocks To ConsiderJanuary 5th - MarketBeat
Promising Healthcare Stocks To Follow NowJanuary 14th - MarketBeat
BofA Maintains an Underperform Rating on Hims & Hers Health, Inc. (HIMS) - Insider Monkey
Hims & Hers: Growth Catalysts Or Margin Trap (NYSE:HIMS) - Seeking Alpha
A Look At Hims & Hers Health (HIMS) Valuation As Amazon Targets The Weight Loss Segment - Sahm
Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - MSN
OMCL vs. HIMS: Which Stock Is the Better Value Option? - Yahoo Finance
Belvedere Trading LLC Sells 35,095 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Why Hims & Hers Health (HIMS) Is Down 6.8% After Amazon Pharmacy Adds Wegovy Weight-Loss Pill - Yahoo Finance
Why Hims & Hers Health, Inc. (HIMS) Outpaced the Stock Market Today - sharewise.com
Hims & Hers Health (HIMS) Receives Sell Rating Amid Overvaluatio - GuruFocus
Is It Too Late To Consider Hims & Hers Health (HIMS) After Its 4x Three-Year Surge? - Sahm
Key facts: Hims & Hers Health faces challenges; Evercore sets price target at $33 - TradingView — Track All Markets
4 Analysts Have This To Say About Hims & Hers Health - Benzinga
HIMS: Bullish Momentum Observed as Shares Rise - GuruFocus
Best Healthcare Stocks To Follow TodayJanuary 12th - MarketBeat
Hims & Hers Expands Platform-Led Access to Provider-Directed Care - The Globe and Mail
Hims & Hers stock is crashing: will it rebound soon? - TradingView — Track All Markets
Evercore ISI Initiates Coverage on Hims (HIMS) with In-Line Rati - GuruFocus
Hims & Hers Health (NYSE:HIMS) Coverage Initiated at Evercore ISI - MarketBeat
Evercore ISI initiates Hims and Hers stock coverage with In Line rating - Investing.com Canada
Hims & Hers Health (HIMS) stock slides premarket after Amazon’s Wegovy pill move — what traders watch next - TechStock²
Why is HIMS stock slipping premarket today? - MSN
Why Is HIMS Stock Slipping Premarket Today? - Stocktwits
Is It Too Late To Consider Hims & Hers Health (HIMS) After Recent Share Price Pullback - Yahoo Finance
A Look At Hims & Hers Health (HIMS) Valuation As Telehealth And Recurring Care Draw Fresh Attention - Yahoo Finance
Trading Systems Reacting to (HIMS) Volatility - Stock Traders Daily
Hims & Hers Expands Care Scope as Prescription Platforms Evolve - MSN
After a 36% Rally in 2025, Is HIMS Stock Still a Good Buy Right Now? - TIKR.com
Hims & Hers Health Inc. Stock (HIMS) Opinions on Recent Price Target Cut - Quiver Quantitative
$HIMS stock fell 6% this week. Here's what we see in our data. - Quiver Quantitative
Hims & Hers stock slides as Amazon adds Wegovy pill, raising fresh pricing fears - TechStock²
Hims & Hers health authorizes $250 million share repurchase program - MSN
Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill - TechStock²
Hims & Hers Health: Capitalizing On Healthcare Innovation (NYSE:HIMS) - Seeking Alpha
Hims & Hers Stock: A Pivotal Year of Investment and Uncertainty - AD HOC NEWS
Hims & Hers Health stock falls after Amazon Pharmacy adds Wegovy pill - Investing.com Canada
Amazon Pharmacy to offer Wegovy pill for as little as $25 a month (AMZN:NASDAQ) - Seeking Alpha
Hims & Hers Health, Inc. $HIMS Shares Sold by SG Americas Securities LLC - MarketBeat
Hims & Hers CEO Bets On Personalized Healthcare And AI In 2026 — Wall Street Braces For A Costly Year - Stocktwits
Hims & Hers Growth Story Has A Lot To Prove In 2026 (NYSE:HIMS) - Seeking Alpha
Hims & Hers Plunges 39.2% in 3 Months: Time to Hold the Stock or Sell? - The Globe and Mail
Hims & Hers: Looking Beyond GLP-1s To The Next Phase Of Global Growth (NYSE:HIMS) - Seeking Alpha
2026: The Year of the Consumer in Healthcare - Hims & Hers Newsroom
HIMS Stock Falls after BofA Slashes Price Target to a Street-Low of $29 - TipRanks
BofA Securities lowers Hims and Hers stock price target on 2026 investment concerns By Investing.com - Investing.com UK
Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List - Stocktwits
Hims & Hers enters 2026 on solid ground — stock rises even after Novo Nordisk leaves it off Wegovy partner list - MSN
Hims & Hers Health: Under-Appreciated Upside (NYSE:HIMS) - Seeking Alpha
Hims & Hers: A Rare GARP Setup After The Market Reset (NYSE:HIMS) - Seeking Alpha
Hims & Hers: Capitalizing On Robust Subscriber/ARPU GrowthUpgraded Buy Rating (NYSE:HIMS) - Seeking Alpha
1.30%
1.45%
자본화:
|
볼륨(24시간):